Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111925356B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand enabling high-yield nickel-catalyzed synthesis of chiral lactams for pharmaceutical intermediates.